Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Immunotherapy × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Lung Neoplasms 2 Small Cell Lung Carcinoma 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Neoplasm, Residual 1 Muscle-invasive Bladder Cancer 1 Melanoma 1 Liver Neoplasms 1 Liver Diseases 1 Digestive System Neoplasms 1 Digestive System Diseases 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Carboplatin 7 Cisplatin 6 pembrolizumab 5 Radiotherapy 5 Paclitaxel 4 Cetuximab 4 Drug Therapy 3 toripalimab 2 osimertinib 2 X-Rays 2 Fulvestrant 2 Fluorouracil 2 Chemoradiotherapy 2 trastuzumab deruxtecan 1 tisotumab vedotin 1 tislelizumab 1 ribociclib 1 pralsetinib 1 pamiparib 1 palbociclib 1 monalizumab 1 fludarabine 1 exemestane 1 entrectinib 1 disitamab vedotin 1 Therapeutics 1 Tablets 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡